Bronstein, Gewirtz & Grossman, LLC Is Investigating Novavax, Inc. (NVAX) And Encourages Stockholders to ConnectAccesswire • 10/16/24
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plungeCNBC • 10/16/24
Novavax's stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidatesMarket Watch • 10/16/24
Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 TrialPRNewsWire • 10/16/24
Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EUPRNewsWire • 10/09/24
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & DevelopmentPRNewsWire • 09/25/24
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?Investors Business Daily • 09/19/24
Is Novavax Stock A Buy Or A Sell In September 2024 On A Mixed Earnings Report?Investors Business Daily • 09/13/24
Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.PRNewsWire • 09/13/24
Novavax, Inc. (NVAX) H.C. Wainwright 26th Annual Global Investment Conference (Transcript)Seeking Alpha • 09/09/24